<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning neuroprotection in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> is male-specific </plain></SENT>
<SENT sid="1" pm="."><plain>The role of <z:chebi fb="5" ids="50113">androgens</z:chebi> in the ischemic sensitivity of <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioned male brain and whether <z:chebi fb="3" ids="50113">androgen</z:chebi> effects are <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor dependent were assessed </plain></SENT>
<SENT sid="2" pm="."><plain>Male C57BL/6 mice were implanted with <z:chebi fb="0" ids="5132">flutamide</z:chebi> (<z:chebi fb="3" ids="50113">androgen</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>), or castrated and implanted with <z:chebi fb="51" ids="17347">testosterone</z:chebi>, <z:chebi fb="1" ids="16330">dihydrotestosterone</z:chebi>, <z:chebi fb="0" ids="5132">flutamide</z:chebi>, <z:chebi fb="0" ids="6413">letrozole</z:chebi> (<z:chebi fb="0" ids="50790">aromatase inhibitor</z:chebi>), or vehicle 7-13 days before preconditioning </plain></SENT>
<SENT sid="3" pm="."><plain>P450 <z:chebi fb="0" ids="50114">estrogen</z:chebi> aromatase <z:mp ids='MP_0002169'>wild-type</z:mp> and knockout mice were also evaluated </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> mice were preconditioned for 4 h with 0% (sham preconditioning) or 1% <z:chebi fb="0" ids="6015">isoflurane</z:chebi> (<z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning) and recovered for 24 h </plain></SENT>
<SENT sid="5" pm="."><plain>Mice then underwent 2 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and were evaluated 22 h later for <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="6" pm="."><plain>For neurobehavioral outcomes, sham and <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioned castrated male+/-<z:chebi fb="1" ids="16330">dihydrotestosterone</z:chebi> groups underwent 1 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 9 days of reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning neuroprotection relative to <z:mpath ids='MPATH_124'>infarct</z:mpath> volume outcomes were <z:chebi fb="51" ids="17347">testosterone</z:chebi> and <z:chebi fb="1" ids="16330">dihydrotestosterone</z:chebi> dose-specific and <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor-dependent </plain></SENT>
<SENT sid="8" pm="."><plain>Relative to long-term neurobehavioral outcomes, front paw sensorimotor function improved in <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioned mice regardless of <z:chebi fb="3" ids="50113">androgen</z:chebi> status while <z:chebi fb="3" ids="50113">androgen</z:chebi> replacement independently improved sensorimotor function </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning improved cognitive function in castrates lacking endogenous <z:chebi fb="5" ids="50113">androgens</z:chebi>, but this improvement was absent in <z:chebi fb="3" ids="50113">androgen</z:chebi> replaced mice </plain></SENT>
<SENT sid="10" pm="."><plain>Our findings suggest that <z:chebi fb="3" ids="50113">androgen</z:chebi> availability during <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning may influence <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and neurobehavioral outcomes in male mice following experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>